|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 48.46 USD | -0.59% |
|
+0.85% | -2.49% |
| 05-13 | Supernus Pharmaceuticals, Inc. Presents at Bank of America Global Healthcare Conference 2026, May-12-2026 03:40 PM | |
| 05-05 | Supernus Pharmaceuticals, Inc., Q1 2026 Earnings Call, May 05, 2026 |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Neutral | Bearish |
| Resistance | 50.44 | 56.32 | 49.47 |
| Spread/Res. | -3.93% | -13.96% | -2.04% |
| Spread/Supp. | +2.58% | +11.20% | +9.19% |
| Support | 47.24 | 43.58 | 44.38 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- SUPN Stock
- Charts Supernus Pharmaceuticals, Inc.
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
